Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study.
Fischer S, Donhauser M, Cohnen S, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, Rath T, Wilfer A, Sologub L, Krebs S, Dörje F, Nagore D, Meyer S, Neurath MF, Atreya R. Fischer S, et al. Among authors: fietkau k. Therap Adv Gastroenterol. 2024 Nov 30;17:17562848241301887. doi: 10.1177/17562848241301887. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39619829 Free PMC article.
Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.
Plechschmidt J, Fietkau K, Hepp T, Dietrich P, Fischer S, Krebs S, Neurath MF, Dörje F, Atreya R. Plechschmidt J, et al. Among authors: fietkau k. Inflamm Bowel Dis. 2024 Mar 20:izae040. doi: 10.1093/ibd/izae040. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38507608
Management of patients with seasonal allergic rhinitis: Diagnostic consideration of sensitization to non-frequent pollen allergens.
Höflich C, Balakirski G, Hajdu Z, Baron JM, Fietkau K, Merk HF, Strassen U, Bier H, Dott W, Mücke HG, Straff W, Wurpts G, Yazdi AS, Chaker A, Röseler STM. Höflich C, et al. Among authors: fietkau k. Clin Transl Allergy. 2021 Oct 4;11(8):e12058. doi: 10.1002/clt2.12058. eCollection 2021 Oct. Clin Transl Allergy. 2021. PMID: 34631010 Free PMC article.
"New" inhalant plant allergens.
Röseler STM, Baron JM, Höflich C, Merk HF, Bas M, Bier H, Dott W, Fietkau K, Hajdu Z, Kaiser L, Kraus T, Laven G, Moll-Slodowy S, Mücke HG, Straff W, Wurpts G, Yazdi AS, Chaker A, Balakirski G. Röseler STM, et al. Among authors: fietkau k. Allergol Select. 2020 Apr 23;4:1-10. doi: 10.5414/ALX02066E. eCollection 2020. Allergol Select. 2020. PMID: 32357199 Free PMC article.
Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.
Allner C, Melde M, Becker E, Fuchs F, Mühl L, Klenske E, Müller L, Morgenstern N, Fietkau K, Hirschmann S, Atreya R, Atreya I, Neurath MF, Zundler S. Allner C, et al. Among authors: fietkau k. BMC Gastroenterol. 2020 Apr 15;20(1):103. doi: 10.1186/s12876-020-01253-8. BMC Gastroenterol. 2020. PMID: 32293299 Free PMC article.
17 results